Dimensional Fund Advisors LP Has $48.08 Million Holdings in Oscar Health, Inc. $OSCR

Dimensional Fund Advisors LP raised its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 22.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,192,777 shares of the company's stock after buying an additional 759,837 shares during the period. Dimensional Fund Advisors LP owned about 1.41% of Oscar Health worth $48,078,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the business. Focus Partners Wealth grew its holdings in Oscar Health by 1.4% during the 3rd quarter. Focus Partners Wealth now owns 57,787 shares of the company's stock worth $1,094,000 after acquiring an additional 824 shares during the last quarter. Equitable Holdings Inc. lifted its stake in shares of Oscar Health by 7.0% in the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company's stock valued at $186,000 after purchasing an additional 850 shares during the period. Captrust Financial Advisors boosted its holdings in Oscar Health by 2.0% during the fourth quarter. Captrust Financial Advisors now owns 45,754 shares of the company's stock worth $657,000 after buying an additional 895 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in Oscar Health by 5.6% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company's stock worth $255,000 after purchasing an additional 938 shares during the period. Finally, Binnacle Investments Inc lifted its holdings in shares of Oscar Health by 28.6% during the 3rd quarter. Binnacle Investments Inc now owns 4,500 shares of the company's stock valued at $85,000 after purchasing an additional 1,000 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Stock Performance

OSCR stock opened at $31.33 on Monday. The firm has a market cap of $9.45 billion, a PE ratio of -53.11, a price-to-earnings-growth ratio of 1.64 and a beta of 2.36. The stock has a 50-day moving average price of $28.24 and a 200-day moving average price of $19.97. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $33.10.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the prior year, the business earned $0.92 earnings per share. The business's quarterly revenue was up 52.6% compared to the same quarter last year. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.63 earnings per share for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Mario Schlosser sold 147,500 shares of the business's stock in a transaction on Tuesday, June 23rd. The stock was sold at an average price of $29.38, for a total value of $4,333,550.00. Following the sale, the director directly owned 1,360,866 shares in the company, valued at $39,982,243.08. The trade was a 9.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Adam Mcananey sold 9,859 shares of the company's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the transaction, the insider directly owned 218,096 shares in the company, valued at $4,785,026.24. This represents a 4.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 3,662,466 shares of company stock worth $105,145,815. Company insiders own 22.64% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the stock an "equal weight" rating in a research report on Thursday, June 4th. Robert W. Baird boosted their target price on Oscar Health from $15.00 to $19.00 and gave the stock a "neutral" rating in a report on Thursday, May 7th. Wall Street Zen raised shares of Oscar Health from a "buy" rating to a "strong-buy" rating in a report on Sunday, June 14th. Wolfe Research assumed coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They issued a "peer perform" rating for the company. Finally, Zacks Research raised Oscar Health from a "hold" rating to a "strong-buy" rating in a report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $22.00.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.